Transcera Overview

  • Year Founded
  • 2020

Year Founded

  • Status
  • Private

  • Employees
  • 4

Employees

  • Latest Deal Type
  • Later Stage VC

  • Investors
  • 10

Transcera General Information

Description

Developer of a lipid-based drug delivery platform designed to improve the treatment of chronic diseases. The company's platform offers large therapeutic molecules to cross cellular barriers and enhances absorption and pharmacokinetics, enabling healthcare professionals to achieve precise and effective targeting of therapeutics for patients with chronic conditions.

Contact Information

Website
www.transcera.com
Formerly Known As
Karivez
Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Corporate Office
  • 700 Main Street
  • Cambridge, MA 02139
  • United States
+1 (317)
Primary Industry
Drug Delivery
Other Industries
Drug Discovery
Biotechnology
Vertical(s)
Nanotechnology, TMT, HealthTech, Life Sciences
Corporate Office
  • 700 Main Street
  • Cambridge, MA 02139
  • United States
+1 (317)

Transcera Timeline

2023202420252026
Financing RoundCaptured Employee CountEstimated Employee Growth

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Transcera Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
6. Later Stage VC 01-Nov-2025 Completed Startup
5. Seed Round 30-Jun-2023 Completed Startup
4. Seed Round 03-Nov-2021 Completed Startup
3. Accelerator/Incubator 28-Oct-2021 Completed Startup
2. Grant 31-Mar-2021 $85K Completed Startup
1. Accelerator/Incubator Completed Startup
To view Transcera’s complete valuation and funding history, request access »

Transcera Cap Table

Stock # of Shares
Authorized		 Par Value Dividend Rate (%) Original
Issue Price		 Liquidation Liquidation
Pref. Multiple		 Conversion Price % Owned
Seed-2
Seed-1
To view Transcera’s complete cap table history, request access »

VC Exit Predictor

See how our proprietary methodology utilizes historical data sets to synthesize the likelihood of an acquisition, IPO, or no exit event. Get a detailed look at the calculations behind our predictions.

Opportunity Score

Calculated using Exit Type probabilities, the company’s stage, and PitchBook’s historical returns data.

Exit Type

Evaluates the likelihood of a successful exit for investors, and the most likely exit type.

Request a free trial

Transcera Patents

  • 2

    Total Documents Applications and Grants

  • Total Patents Families

  • Granted

  • 2

    Pending

  • Expiring in next 12 mo

Transcera Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
WO-2025213153-A2 Compounds for lysosomal degradation of target proteins Pending 05-Apr-2024
WO-2025213153-A3 Compounds for lysosomal degradation of target proteins Pending 05-Apr-2024

Transcera Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Transcera Investors (10)

Investor Name Investor Type Holding Investor Since Participating Rounds
Portal Innovations Venture Capital Minority
KdT Ventures Venture Capital Minority
Pear (California) Venture Capital Minority
Rho Acceleration Venture Capital Minority
Xora Innovation Venture Capital Minority
You’re viewing 5 of 10 investors. Get the full list »

Ready to get started?

Request a free trial

Transcera FAQs

  • When was Transcera founded?

    Transcera was founded in 2020.

  • Where is Transcera headquartered?

    Transcera is headquartered in Cambridge, MA.

  • What is the size of Transcera?

    Transcera has 4 total employees.

  • What industry is Transcera in?

    Transcera’s primary industry is Drug Delivery.

  • Is Transcera a private or public company?

    Transcera is a Private company.

  • What is Transcera’s current revenue?

    The current revenue for Transcera is .

  • How much funding has Transcera raised over time?

    Transcera has raised $5.38M.

  • Who are Transcera’s investors?

    Portal Innovations, KdT Ventures, Pear (California), Rho Acceleration, and Xora Innovation are 5 of 10 investors who have invested in Transcera.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more

  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process